Bio-Techne's shares have rebounded to around $65, but a deep dive into valuation metrics reveals a complex picture. While a discounted cash flow model suggests the stock is near fair value, its sky-high P/E ratio tells a different story, raising questions about its long-term prospects.
Strong quarterly results and bullish guidance from data analytics firm Palantir Technologies have fueled a pre-market surge in tech stocks, setting a positive tone for Wall Street as investors digest mixed economic signals and await key earnings reports.
Convenience store chain Spinx is deploying Tote AI's integrated platform across all locations, aiming to unify operations, enhance foodservice tech, and modernize point-of-sale systems for deeper data insights and future agility.
Recent volatility in Genscript Biotech's (SEHK:1548) share price has investors questioning its true worth. While short-term gains offer a glimmer, a deeper look reveals a stark three-year decline, setting the stage for a critical valuation debate.
As Saudi Arabia launches a National Savings Strategy, fintech startup Hakbah is bringing the traditional 'jameya' savings model online, tapping into a young user base and awaiting pivotal new regulations to scale its impact.
Biosimilars developer Alvotech (NASDAQ: ALVO) presents a complex picture for investors, with recent short-term share price gains starkly contrasted by a punishing 57% decline over the past year. As the stock trades at a significant discount to some analyst targets, the market debates whether this signals a prime opportunity or reflects deeper, unresolved challenges.
Hospitality tech firm Shiji marks a significant deployment milestone for its Infrasys POS system at a U.S. Hyatt, enhancing operational efficiency and guest experience across the hotel group's global portfolio.
Roche's Genentech secures exclusive global rights to a promising RNAi program from China-based SanegeneBio, which receives a $200 million upfront payment and could earn over $1.3 billion in milestones.
At Web Summit Qatar, Al Jazeera's Director General warned that algorithmic systems are deepening societal divides and unveiled a major initiative to redefine journalism's role by merging technology with ethical reporting.
As consumer sentiment sours, investors are pivoting to sectors like financial technology and home construction, anticipating policy moves from Washington aimed at easing cost-of-living pressures before the November elections.
Himax Technologies' stock has declined 9% over the past quarter, prompting a closer look at its underlying financial health. A low Return on Equity and high dividend payout ratio raise questions about its growth trajectory in a competitive semiconductor landscape.
Amidst a challenging macroeconomic climate of steady rates and low consumer confidence, a select group of technology firms are demonstrating remarkable resilience. We examine three companies from the Global High Growth Tech and AI screener that are leveraging innovation to outpace their markets.
Bank of America has increased its price target for healthcare giant Johnson & Johnson to $227, highlighting its defensive investment profile and growth in MedTech, while downplaying the financial impact of ongoing talc litigation.
Alibaba's logistics arm, Cainiao, is set to acquire a stake in robovan developer Zelostech, creating a combined entity valued at approximately $2 billion. The strategic move, aimed at bolstering its autonomous freight capabilities, comes as China Merchants Securities reiterates a Buy rating on Alibaba with a HK$194 price target.
As generative AI floods the digital landscape with 'slop,' tech giants from Microsoft to Anthropic are engaged in a high-stakes bidding war for a different kind of talent: master communicators and storytellers commanding salaries nearing $1 million.
Japan's benchmark Nikkei 225 index surged nearly 4% to a historic close, powered by robust earnings from technology and financial heavyweights and a broader revival of investor confidence across Asian markets.
As market concentration reaches historic levels, investors are searching for sustainable growth beyond the usual megacap suspects. We analyze Appian, JFrog, and Lam Research, separating potential from peril in today's volatile tech landscape.
A sharp afternoon selloff dragged Hong Kong's benchmark tech gauge to the edge of a bear market, with losses led by sector giants. Investor anxiety is mounting over potential new taxes for internet companies, compounding existing pressures from valuation concerns and intense domestic competition.
Chinese chip designer Montage Technology has priced its Hong Kong secondary listing at the top of its indicated range, raising HK$7.04 billion ($902 million) in a vote of confidence for China's semiconductor sector amid ongoing global supply chain tensions.
The third-quarter earnings season for healthcare technology providers revealed a sector in transition, with companies like Astrana Health posting strong revenue gains but facing investor scrutiny over profitability and guidance. While digital transformation tailwinds persist, adoption challenges and tightening hospital budgets are testing the industry's growth narrative.
